Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Endpoints beyond fracture promise to facilitate shorter trials, new osteoporosis research Regina Schaffer
-
- For answers to type 2 diabetes, look for multitaskers Debbie Thurmond, PhD
- Artificial pancreas may be safe for young children with type 1 diabetes Michael Monostra
- Assess social determinants of health to limit disparities for people with diabetes Regina Schaffer
- Cancer replaces vascular disease as leading cause of excess death in diabetes Regina Schaffer
- CKD progression risk ‘modest’ with bisphosphonate use Regina Schaffer
- Estradiol may influence association between HDL cholesterol, aortic calcification Michael Monostra
- FDA grants tentative approval to oral testosterone for men with hypogonadism Regina Schaffer
- Long-term antithyroid drugs effective therapy for Graves’ disease Michael Monostra
-
- Lower death risk with normal weight transition to overweight vs. other BMI trajectories Michael Monostra
- Lower energy intake observed in low-fat vegan vs. low-carb ketogenic diet Michael Monostra
- Menstrual cycle tracking app may increase odds for conception Michael Monostra
- Metabolic improvements seen 26 weeks after fecal microbiome transfer for teens Michael Monostra
- Obesity’s cardiometabolic effects greater for Chinese vs. Black, white adults Regina Schaffer
- Once-monthly monoclonal antibody reduces body fat, increases muscle in obesity, diabetes Regina Schaffer
- Overweight during pregnancy may raise odds of infertility in adult sons Regina Schaffer
- Elevated risk for CV events in adulthood seen with children on GH therapy Michael Monostra
-
- Pituitary region tumors comprise ‘significant proportion’ of pediatric brain tumors Michael Monostra
- Risks for diabetes, cardiometabolic disorders rise with obesity duration Michael Monostra
- Thyroid dysfunction highly prevalent in Cushing’s syndrome Michael Monostra
- Weekly semaglutide injection associated with substantial weight loss in obesity Regina Schaffer
- Will BMD as sole endpoint be a competitive disadvantage for new osteoporosis drugs?